What the report is for
Use this report before a founder pays for a broad regulatory consulting engagement, asks a manufacturer for launch support, or enters investor diligence with only a slide-level regulatory story.
- Prepare consultant intake so paid expert time starts with review instead of raw searching.
- Turn public FDA records into a source ledger rather than a folder of links.
- Separate source-backed facts, founder assumptions, and decisions that still belong to a qualified reviewer.
- Give the next reviewer one product definition, one evidence map, and one question list.
What to include
| Report section | What goes inside | Why it matters |
|---|---|---|
| Product definition | Device name, intended user, use environment, technology, accessories, software, and claim assumptions. | A reviewer cannot assess market-entry clues without knowing what product is being discussed. |
| Public source ledger | FDA database links, record identifiers, source dates, and notes on what each source can and cannot show. | It prevents the first consultant call from becoming a search recap. |
| Comparator and product-code clues | Candidate product codes, similar devices, 510(k) records, and difference notes. | These are review inputs, not conclusions. |
| Open questions | Classification, pathway, predicate, testing, labeling, importer, and distributor questions. | The report should make professional judgment easier to apply. |
What public evidence can show
Public records can reveal patterns worth reviewing: similar device names, applicant names, product-code clues, regulation citations, 510(k) decision dates, and sometimes 510(k) summaries. Those are useful because they make the next review concrete.
They are not a substitute for product-specific analysis. A similar-looking device name can hide different intended use, technology, indications, risk, labeling, or testing expectations.
What remains for qualified review
- Final classification and product-code applicability.
- Whether 510(k), De Novo, Premarket Approval (PMA), exemption, or another path should be discussed.
- Predicate suitability and substantial equivalence strategy.
- Labeling, claims, performance testing, safety, effectiveness, quality-system, and legal obligations.
What TrueMedDevice can prepare
TrueMedDevice prepares the research report layer: product identity worksheet, public source ledger, comparator clues, safety-history review points, role questions, open reviewer questions, and a handoff packet for the consultant or regulatory affairs and quality assurance (RA/QA) reviewer.
The result is not a regulatory opinion. It is the structured evidence base that helps the next qualified reviewer move faster and leaves a durable record of what was checked.
Source ledger
What it can tell you
FDA's high-level sequence for studying and marketing a medical device in the United States.
What it cannot decide
Your product's final regulatory path, evidence burden, clearance status, or launch readiness.
What it can tell you
Public product-code, device-name, classification, panel, and regulation clues that may help frame a reviewer question.
What it cannot decide
Whether a product code, class, or regulation applies to your specific device.
What it can tell you
Where to search public 510(k) clearance records and related device summaries when available.
What it cannot decide
Whether a public device is a suitable predicate or whether your device is substantially equivalent.
What it can tell you
General registration and listing context for medical device establishments and device records.
What it cannot decide
Whether your company is ready to register, list, import, distribute, label, or commercially launch.
Frequently asked questions
Can a medical device market entry research report replace a consultant?
No. It prepares source-backed context so a consultant or RA/QA reviewer can spend more time on judgment and less time on basic evidence collection.
Can public FDA databases identify my regulatory pathway?
They can provide useful clues, but they do not determine the pathway for your specific product, claims, technology, evidence set, or launch plan.
When should a founder prepare this report?
Before the first paid consultant meeting, investor diligence, manufacturer onboarding, distributor discussion, or product-definition decision that could lock in the wrong assumptions.
Want the consultant call to start from evidence?
Request a Market Entrance Preparation Pack for one product. We organize product facts, FDA public-source clues, comparator records, role questions, and reviewer-ready open questions before paid strategy time starts.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.